Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome

Journal of Comparative Neurology

Volumn 480, Issue 3, 2004, Pages 281-298

  Belichenko, Pavel V ^a   Masliah, Eliezer ^b   Kleschevnikov, Alexander M ^a   Villar, Angela J ^c   Epstein, Charles J ^c   Salehi, Ahmad ^a   Mobley, William C ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Down syndrome; Morphometry; Spines; Synapses; Ts65Dn

Indexed keywords

LUCIFER YELLOW;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN SIZE; CELL DENSITY; COGNITIVE DEFECT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC SPINE; DENTATE GYRUS; DOWN SYNDROME; ELECTRON MICROSCOPY; ENTORHINAL CORTEX; GENETIC MODEL; GRANULE CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LONG TERM POTENTIATION; MALE; MICROINJECTION; MORPHOMETRICS; MOTOR CORTEX; MOUSE; MOUSE STRAIN; NERVE CONDUCTION; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SENSORY STIMULATION; SOMATOSENSORY CORTEX; STRUCTURE ANALYSIS; SYNAPSE; TISSUE STRUCTURE; ULTRASTRUCTURE;

ANIMALS; BRAIN; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; DOWN SYNDROME; FEMALE; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; MOTOR CORTEX; PRESYNAPTIC TERMINALS; REFERENCE VALUES; SOMATOSENSORY CORTEX; SYNAPSES;

EID: 9644278035     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20337     Document Type: Article

References (80)

1. Alford MF, Masliah E, Hansen LA, Terry RD. 1994. A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain. J Histochem Cytochem 42:283-287.
2. Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH. 2000. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 9:195-202.
3. Becker LE, Armstrong DL, Chan F. 1986. Dendritic atrophy in children with Down's syndrome. Ann Neurol 20:520-526.
4. Belichenko PV, Dahlström A. 1994. Dual channel confocal laser scanning microscopy of Lucifer yellow-microinjected human brain cells combined with Texas red immunofluorescence. J Neurosci Methods 52:111-118.
5. Belichenko PV, Dahlström A. 1995. Mapping of the human brain in normal and pathology: the single cell and fiber level, employing Lucifer yellow microinjection, carbocyanine dyes tracing, immunofluorescence, and 3-D confocal laser scanning reconstruction. Neurosci Protoc 95-050-03-01-30.
6. Belichenko PV, Fedorov AA, Dahlström A. 1996. Quantitative analysis of immunofluorescence and lipofuscin distribution in human cortical areas by dual-channel confocal laser scanning microscopy. J Neurosci Methods 69:155-161.
7. Bellocchio EE, Reimer RJ, Fremeau RT, Edwards RH. 2000. Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289:957-960.
8. Buckmaster PS, Yamawaki R, Zhang GF. 2002. Axon arbors and synaptic connections of a vulnerable population of interneurons in the dentate gyrus in vivo. J Comp Neurol 445:360-373.
9. Casanova MF, Walker LC, Whitehouse PJ, Price DL. 1985. Abnormalities of the nucleus basalis in Down's syndrome. Ann Neurol 18:310-313.
10. Chapman RS, Hesketh LJ. 2000. Behavioral phenotype of individuals with Down syndrome. MRDD Res Rev 6:84-95.
11. Chaudhry FA, Reimer RJ, Bellocchio EE, Danbolt NC, Osen KK, Edwards RH, Storm-Mathisen J. 1998. The vesicular GABA transporter, VGAT, localized to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J Neurosci 18:9733-9750.
12. Chen SC, Hillman DE. 1990. Robust synaptic plasticity of striatal cells following partial deafferentation. Brain Res 520:103-114.
13. Chen-Hwang MC, Chen HR, Elzinga M, Hwang YW. 2002. Dynamin is a minibrain kinase/dual specificity Yak1-related kinase IA substrate. J Biol Chem 277:17597-17604.
14. Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J, Kilbridge JF, Carlson EJ, Epstein CJ, Mobley WC. 2001. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci U S A 98:10439-10444.
15. Cossart R, Esclapez M, Hirsch JC, Bernard C, Ben-Ari Y. 1998. GluR5 kainate receptor activation in interneuron increases tonic inhibition of pyramidal cells. Nat Neurosci 1:470-478.
16. Costa AC, Walsh K, Davisson MT. 1999. Motor dysfunction in a mouse model for Down syndrome. Physiol Behav 68:211-220.
17. Cragg BG. 1975. The density of synapses and neurons in normal, mentally defective and ageing human brains. Brain 98:81-90.
18. DeFelipe J, Farinas I. 1992. The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. Prog Neurobiol 39:563-607.
19. Demas GE, Nelson RJ, Krueger BK, Yarowsky PJ. 1996. Spatial memory deficits in segmental trisomic Ts65Dn mice. Behav Brain Res 82:85-92.
20. Demas GE, Nelson RJ, Krueger BK, Yarowsky PJ. 1998. Impared spatial working memory in segmental trisomy (Ts65Dn) mice. Behav Brain Res 90:199-201.
21. Dierssen M, Benavides-Piccione R, Martinez-Cue C, Estivill X, Florez J, Elston GN, DeFelipe J. 2003. Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: effects of environmental enrichment. Cereb Cortex 13:758-764.
22. El-Husseini AED, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS. 2000. PSD-95 involvement in maturation of excitatory synapses. Science 290:1364-1368.
23. Escorihuela RM, Fernandez-Teruel A, Vallina IF, Baamonde C, Lumbreras MA, Dierssen M, Tobena A, Florez J. 1995. A behavioral assessment of Ts65Dn mice: a putative Down syndrome model. Neurosci Lett 199: 143-146.
24. Escorihuela RM, Vallina IF, Martinez-Cue C, Baamonde C, Dierssen M, Tobena A, Florez J, Fernandez-Teruel A. 1998. Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome. Neurosci Lett 247:171-174.
25. Ferrer I, Gullotta F. 1990. Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus. Acta Neuropathol 79:680-685.
26. Fiala JC, Spacek J, Harris KM. 2002. Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res Rev 39:29-54.
27. Frerking M, Malenka RC, Nicoll RA. 1998. Synaptic activation of kainite receptors on hippocampal interneurons. Nat Neurosci 1:479-486.
28. Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, Estivill X, de la Luna S. 2000. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9:1681-1690.
29. Gardiner K, Fortna A, Bechtel L, Davisson MT. 2003. Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene 318:137-147.
30. Garner CC, Zhai RG, Gundelfinger ED, Ziv NE. 2002. Molecular mechanisms of CNS synaptogenesis. Trends Neurosci 25:243-250.
31. Granholm AC, Sanders LA, Crnic LS. 2000. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome. Exp Neurol 161:647-663.
32. Gray EG. 1959. Axo-somatic and axo-dendritic synapses of the cerebral cortex: an electron microscope study. J Anat 93:420-433.
33. Halasy K, Somogyi P. 1993. Distribution of GABAergic synapses and their targets in the dentate gyrus of rat: a quantitative immunoelectron microscopic analysis. J Hirnforsch 34:299-308.
34. Hillman DE, Chen S. 1984. Reciprocal relationship between size of postsynaptic densities and their number: constancy in contact area. Brain Res 295:325-343.
35. Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE, Johnson RM, Chen K, Sun Y, Carlson E, Alleva E, Epstein CJ, Mobley WC. 1996. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci U S A 93:13333-13338.
36. Hyde LA, Frisone DF, Crnic LS. 2001. Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function. Behav Brain Res 118:53-60.
37. Insausti AM, Megias M, Crespo D, Cruz-Orive LM, Dierssen M, Vallina IF, Insausti R, Florez J, Vallina TF, Vallina IF. 1998. Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of Down syndrome. Neurosci Lett 253:175-178.
38. Katona I, Acsady L, Freund TF. 1999. Postsynaptic targets of somatostatin-immunoreactive interneurons in the rat hippocampus. Neurosci 88:37-55.
39. Keller A. 2002. Use-dependent inhibition of dendritic spines. Trends Neurosci 25:541-543.
40. Kleschevnikov AM, Belichenko PV, Villar AJ, Epstein CJ, Malenka RC, Mobley WC. 2004. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci 24:8153-8160.
41. Kurt MA, Davies DC, Kidd M, Dierssen M, Florez J. 2000. Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice. Brain Res 858:191-197.
42. Lai F, Williams RS. 1989. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 46:849-853.
43. Li Z, Sheng M. 2003. Some assembly required: the development of neuronal synapses. Nat Rev 4:833-841.
44. Marin-Padilla M. 1972. Structural abnormalities of the cerebral cortex in human chromosomal aberrations: a Golgi study. Brain Res 44:625-629.
45. Marin-Padilla M. 1976. Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study. J Comp Neurol 167:63-81.
46. Marti E, Altafaj X, Dierssen M, de la Luna S, Fotaki V, Alvarez M, Peres-Riba M, Ferrer I, Estivill X. 2003. Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. Brain Res 964:250-263.
47. Mertens AF, Roovers RC, Collard JG. 2003. Regulation of Tiam1-Rac signaling. FEBS Lett 546:11-16.
48. Mouton PR. 2002. Principles and practices of unbiased stereology: an introduction for bioscientists. Baltimore: The Johns Hopkins University Press. 214 p.
49. Murthy VN, Schikorski T, Stevens CF, Zhu Y. 2001. Inactivity produces increases in neurotransmitter release and synapse size. Neuron 32: 673-682.
50. O'Bryan JP, Mohney RP, Oldham CE. 2001. Mitogenesis and endocytosis: what's at the intersection? Oncogene 20:6300-6308.
51. Pak DTS, Yang S, Rudolph-Correia S, Kim E, Sheng M. 2001. Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP. Neuron 31:289-303.
52. Pennington BF, Moon J, Edgin J, Stedron J, Nagel L. 2003. The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev 74:75-93.
53. Penzes P, Johnson RC, Sattler R, Zhang X, Huganir RL, Kambampati V, Mains RE, Eipper BA. 2001. The neuronal Rho-GEF kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis. Neuron 29:229-242.
54. Pinter JD, Eliez S, Schmitt JE, Capone GT, Reiss AL. 2001a. Neuroanatomy of Down's syndrome: a high-resolution MRI study. Am J Psychiatry 158:1659-1665.
55. Pinter JD, Brown WE, Eliez S, Schmitt JE, Capone GT, Reiss AL. 2001b. Amygdala and hippocampal volumes in children with Down syndrome: a high-resolution MRI study. Neurology 56:972-974.
56. Purpura DP. 1975. Normal and aberrant neuronal development in the cerebral cortex of human fetus and young infant. In: Buchwald NA, Brazier MAB, editors. Brain mechanisms in mental retardation. New York: Academic Press, p 141-169.
57. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmid C, Bronson RT, Davisson MT. 1995. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11:109-111.
58. Roizen NJ, Patterson D. 2003. Down's syndrome. Lancet 361:1281-1289.
59. Ross MH, Galaburda AM, Kemper TL. 1984. Down's syndrome: is there a decreased population of neurons? Neurology 34:909-916.
60. Rumbaugh G, Sia G, Garner CC, Huganir RL. 2003. Synapse-associated protein-97 isoform-specific regulation of surface AMPA receptors and synaptic function in cultured neurons. J Neurosci 23:4567-4576.
61. Sago H, Carlson EJ, Smith DJ, Rubin EM, Crnic LS, Huang TT, Epstein CJ. 2000. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatric Res 48:606-613.
62. Sala C, Piech V, Wilson NR, Passafaro M, Liu G, Sheng M. 2001. Regulation of dendritic spine morphology and synaptic function by shank and homer. Neuron 31:115-130.
63. Schafer DA. 2002. Coupling actin dynamics and membrane dynamics during endocytosis. Curr Opin Cell Biol 14:76-81.
64. Schikorski T, Stevens CF. 1999. Quantitative fine-structural analysis of olfactory cortical synapses. Proc Natl Acad Sci U S A 96:4107-4112.
65. Schmid SL, McNinen MA, De Camilli P. 1998. Dynamin and its partners: a progress report. Curr Opin Cell Biol 10:504-512.
66. Schmidt-Sidor B, Wisniewski KE, Shepard TH, Sersen EA. 1990. Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin Neuropathol 9:181-190.
67. Siarey RJ, Stoll J, Rapoport SI, Galdzicki Z. 1997. Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down syndrome. Neuropharmacology 36:1549-1554.
68. 2+ signaling pathways in GABAergic neurons of the hippocampus. Proc Natl Acad Sci U S A 95:3245-3250.
69. Slepnev VI, De Camilli P. 2000. Accessory factors in clatrin-dependent synaptic vesicle endocytosis. Nat Rev Neurosci 1:161-172.
70. Stamnes M. 2002. Regulating the actin cytoskeleton during vesicular transport. Curr Opin Cell Biol 14:428-433.
71. Suetsugu M, Mehraein P. 1980. Spine distribution along the apical dendrites of the pyramidal neurons in Down's syndrome. Acta Neuropathol 50:207-210.
72. Takashima S, Becker LE, Armstrong DL, Chan F. 1981. Abnormal neuronal development in the visual cortex of the human fetus and infant with Down's syndrome. A quantitative and qualitative Golgi study. Brain Res 225:1-21.
73. Takashima S, Iida T, Mito T, Arima M. 1994. Dendritic and histochemical development and ageing in patients with Down's syndrome. J Intellect Disabil Res 38:265-273.
74. Trommald M, Hulleberg G. 1997. Dimensions and density of dendritic spines from rat dentate granule cells based on reconstructions from serial electron micrographs. J Comp Neurol 377:15-28.
75. Decker A, Mangan PA, Obrzut JE, Nagel L. 1993. Down syndrome in neurobiological perspective: an emphasis on spatial cognition. J Clin Child Psychol 22:266-276.
76. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. 1982. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-1239.
77. Wisniewski KE. 1990. Down syndrome children often have brain maturation delay, retardation of growth and cortical dysgenesis. Am J Med Genet Suppl 7:274-281.
78. Wisniewski KE, Laure-Kaminowska M, Wisniewski HM. 1984. Evidence of arrest of neurogenesis and synaptogenesis in Down syndrome brains. N Engl J Med 311:1187-1188.
79. Wisniewski KE, Wisniewski HM, Wen GY. 1985. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17:278-282.
80. Yuste R, Bonhoeffer T. 2001. Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci 24: 1071-1089.